All Stories

  1. Glucagon-Like Peptide-1 Receptor Agonists in Individuals With Severe Mental Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  2. Diagnostic and clinical utility of exome sequencing and chromosomal microarray in children with GDD/iD: a meta-analysis
  3. Efficacy and acceptability of S-adenosyl-L-methionine (SAMe) for depressed patients: A systematic review and meta- analysis
  4. Second-generation antipsychotics for Parkinson's disease psychosis: A systematic review and network meta-analysis
  5. Efficacy and acceptability of vitamin D supplements for depressed patients: A systematic review and meta-analysis of randomized controlled trials
  6. Aortic Peak Flow Velocity As a Predictor of Fluid Responsiveness in Mechanically Ventilated Children: A Systematic Review and Meta-Analysis
  7. Convergent Validity of the Edinburgh Postnatal Depression Scale and the Patient Health Questionnaire (PHQ-9) in Pregnant and Postpartum Women: Their Construct Correlations with Functional Disability
  8. Serum oxytocin and corticotropin-releasing hormone levels in the third trimester of pregnancy for predicting postpartum depression in Thai women
  9. Efficacy and acceptability of blue-wavelength light therapy for post-TBI behavioral symptoms: A systematic review and meta-analysis of randomized controlled trials
  10. Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
  11. Antidepressants for depressed patients with type 2 diabetes mellitus: A systematic review and network meta-analysis of short-term randomized controlled trials
  12. The bidirectional relationship between obesity and executive function in children and adolescents
  13. Course and predictors of disability in Thai patients with schizophrenia: A 2-year, multi-center, prospective, observational study
  14. The Effects of Neurofeedback on Executive Functioning in Children With ADHD: A Meta-Analysis
  15. Thai Medical and Nursing Students: COVID-19 Fear Associated with Mental Health and Substance Use
  16. Cross national comparison of medical students’ attitudes and beliefs about medical cannabis and its application for pain management
  17. A meta-analysis comparing short-term weight and cardiometabolic changes between olanzapine/samidorphan and olanzapine
  18. A network meta-analysis of the dose–response effects of lurasidone on acute schizophrenia
  19. Blue-wavelength light therapy for post-traumatic brain injury sleepiness, sleep disturbance, depression, and fatigue: A systematic review and network meta-analysis
  20. Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis
  21. Omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation for prevention and treatment of perinatal depression: a systematic review and meta-analysis of randomized-controlled trials
  22. The Effect of Mindfulness-Based Intervention on Brain-Derived Neurotrophic Factor (BDNF): A Systematic Review and Meta-Analysis of Controlled Trials
  23. Development and implementation of guidelines for the management of depression: a systematic review
  24. Blue-wavelength Light Therapy for Post-traumatic Brain Injury Sleepiness, Sleep Disturbance, Depression, Fatigue: A Systematic Review and Network Meta-analysis
  25. Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand
  26. Efficacy and acceptability of varenicline for alcoholism: A systematic review and meta-analysis of randomized-controlled trials
  27. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand
  28. Subjective depressive symptoms associated with pain in patients with major depressive disorder: Findings from the study on the aspect of Asian depression
  29. Perception of Stigma and Its Associated Factors Among Patients With Major Depressive Disorder: A Multicenter Survey From an Asian Population
  30. Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis
  31. Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
  32. Risperidone for children and adolescents with autism spectrum disorder: a systematic review
  33. Cognitive complaints and predictors of perceived cognitive dysfunction in adults with major depressive disorder: Findings from the Cognitive Dysfunction in Asians with Depression (CogDAD) study
  34. Polydrug use among kratom users: Findings from the 2011 Thailand National Household Survey
  35. Cognitive Dysfunction in Asian Patients with Depression (CogDAD): A Cross-Sectional Study
  36. Cognitive Dysfunction in Asian Patients with Depression (CogDAD): A Cross-Sectional Study
  37. Depression in Kidney Transplant Recipients
  38. Internal consistency and concurrent validity of the Montreal Cognitive Assessment in individuals with major depressive disorder
  39. Clinical and socio-demographic correlates of anxious distress in Asian outpatients with major depressive disorder
  40. Discrepancy between objective and subjective cognition in adults with major depressive disorder
  41. Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
  42. Delirium after a traumatic brain injury: predictors and symptom patterns
  43. Gender Differences in Depressive Symptoms in Thai Individuals with Depressed Mood and/or Anhedonia: A Differential Item Functioning Approach
  44. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials
  45. Comparative efficacy, acceptability, and tolerability of dexmethylphenidate versus placebo in child and adolescent ADHD: a meta-analysis of randomized controlled trials
  46. Clinical and sociodemographic correlates of severe insomnia in psychotropic drug-free, Asian outpatients with major depressive disorder
  47. Correlates of health-related quality of life in Thai patients with alcohol dependence
  48. Psychosocial functioning in schizophrenia: are some symptoms or demographic characteristics predictors across the functioning domains?
  49. Routledge Handbook of Psychiatry in Asia
  50. The association of suicide risk with negative life events and social support according to gender in Asian patients with major depressive disorder
  51. Correlates of Disability in Asian Patients With Major Depressive Disorder
  52. Stressful life events preceding the onset of depression in Asian patients with major depressive disorder
  53. Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials
  54. Efficacy and safety of aripiprazole augmentation of clozapine in schizophrenia: A systematic review and meta-analysis of randomized-controlled trials
  55. Is Early-onset in Major Depression a Predictor of Specific Clinical Features with More Impaired Social Function?
  56. Subjective memory and concentration deficits in medication-free, non-elderly Asians with major depressive disorder: Prevalence and their correlates
  57. Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD
  58. P.1.g.011 A systematic review of randomised controlled trials of lisdexamfetamine versus placebo in the treatment of adults with ADHD
  59. Relaxation for perimenopausal and postmenopausal symptoms
  60. Quetiapine for acute bipolar depression: a systematic review and meta-analysis
  61. Risk factors for an anxiety disorder comorbidity among Thai patients with bipolar disorder: results from the Thai Bipolar Disorder Registry
  62. Treatment for amphetamine dependence and abuse
  63. Suicide risk among Thai illicit drug users with and without mental/alcohol use disorders
  64. Clinical and sociodemographic correlates of suicidality in patients with major depressive disorder from six Asian countries
  65. EPA-0239 – Quetiapine for acute bipolar depression: a systematic review and meta-analysis
  66. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: A 12-week, randomized, placebo-controlled trial
  67. Correlates of current suicide risk among Thai patients with bipolar I disorder: findings from the Thai Bipolar Disorder Registry
  68. Effectiveness of a modified version of the applied relaxation technique in treatment of perimenopausal and postmenopausal symptoms
  69. Differences in psychiatric symptoms among Asian patients with depression: A multi-country cross-sectional study
  70. Modified relaxation technique for treating hypertension in Thai postmenopausal women
  71. Clinical features of depression in Asia: Results of a large prospective, cross-sectional study
  72. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized–controlled trials comparison with venlafaxine
  73. Time to relapse and remission of bipolar disorder: findings from a 1-year prospective study in Thailand
  74. Prevalence and predictors of pain in patients with major depressive disorder
  75. Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial
  76. Melancholic features and hostility are associated with suicidality risk in Asian patients with major depressive disorder
  77. Quetiapine versus typical antipsychotic medications for schizophrenia
  78. Addiction potential of phentermine prescribed during long-term treatment of obesity
  79. Reliability and validity of the Thai version of the Calgary Depression Scale for Schizophrenia
  80. 1564 – Reliability and validity of the thai version of the calgary depression scale for schizophrenia
  81. 462 – Quetiapine monotherapy in acute phase for major depressive disorder: a metaanalysis of randomized, placebo-controlled trials
  82. Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drug use: Findings from the 2008 Thai National Mental Health survey
  83. P.6.a.007 Topiramate for alcoholism in patients recently receiving inpatient detoxification: a 12-week, randomised, placebo-controlled trial
  84. Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials
  85. Cognitive changes in topiramate-treated patients with alcoholism: A 12-week prospective study in patients recently detoxified
  86. Patterns of alcohol dependence in Thai drinkers: A differential item functioning analysis of gender and age bias
  87. Bupropion for adults with attention-deficit hyperactivity disorder: Meta-analysis of randomized, placebo-controlled trials
  88. P.5.e.002 A double-blind, randomised, controlled trial of quetiapine versus haloperidol for the treatment of delirium: a preliminary report
  89. P.3.a.005 Prevalence of pain and its correlation to depression: a cross-section study in major depressive patients
  90. P.6.a.004 Endorsement patterns of DSM-IV alcohol dependence criteria in Thai women and adolescents: a differential item functioning approach
  91. S28-01 The Clinical Features of Depression in Asia: Results of a Large, Prospective, Cross-Sectional Study
  92. Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: A 12-week, randomized, controlled trial
  93. Comparisons of methamphetamine psychotic and schizophrenic symptoms: A differential item functioning analysis
  94. Opioid antagonists for alcohol dependence
  95. Treatment for inhalant dependence and abuse
  96. Methamphetamine Psychosis in Australia, Philippines, and Thailand
  97. Relaxation for perimenopausal and postmenopausal symptoms
  98. Quetiapine versus other atypical antipsychotics for schizophrenia
  99. Quetiapine versus typical antipsychotic medications for schizophrenia
  100. Treatment for inhalant dependence and abuse
  101. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual
  102. Psychometric evaluation of the Amphetamine Cessation Symptom Assessment
  103. Quetiapine versus other atypical antipsychotics for schizophrenia
  104. The treatment of alcohol dependence
  105. Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study
  106. Interventions to reduce benzodiazepine prescribing
  107. Brief Intervention for Students with Methamphetamine Use Disorders: A Randomized Controlled Trial
  108. P.5.e.002 An open-label study of quetiapine for delirium
  109. P.6.a.007 Risks and pattern of alcohol withdrawal delirium
  110. P.6.c.001 Benzodiazepines misuse in outpatients treated by internists
  111. The nature, time course and severity of methamphetamine withdrawal
  112. Benzodiazepine prescribing behaviour and attitudes: a survey among general practitioners practicing in northern Thailand
  113. Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials
  114. Opioid antagonists for alcohol dependence
  115. Interventions to reduce benzodiazepine prescribing
  116. Quetiapine for schizophrenia
  117. Psychotic symptoms in methamphetamine psychotic in-patients
  118. A factor structure of methamphetamine psychotic symptoms
  119. Opioid antagonists for alcohol dependence
  120. Impact on Thai Psychiatrists of Passive Dissemination of a Clinical Practice Guideline on Prescribing Attitudes in Treatment-Resistant Schizophrenia
  121. Treatment for amphetamine withdrawal
  122. Treatment for amphetamine dependence and abuse
  123. Treatment for amphetamine psychosis
  124. HIV-Seropositive Results, Health-Related Quality of Life, and Social Support: A 24-Week Prospective Study in Thailand
  125. A factor analysis of amphetamine psychotic symptoms: Preliminary results
  126. Does the Addition of Pindolol Accelerate the Response to Electroconvulsive Therapy in Patients with Major Depression? A Double-Blind, Placebo-Controlled Pilot Study
  127. Quetiapine for schizophrenia
  128. Evaluation of three simple methods for predicting therapeutic lithium doses
  129. Seasonal variations in mood and behaviour: epidemiological findings in the north tropics
  130. Amphetamine Withdrawal: I. Reliability, Validity and Factor Structure of a Measure
  131. Amphetamine Withdrawal: II. A Placebo-Controlled, Randomised, Double-Blind Study of Amineptine Treatment
  132. Amitriptyline vs. lorazepam in the treatment of opiate-withdrawal insomnia: a randomized double-blind study
  133. COMPARATIVE STUDIES OF THE BIOLOGICAL DISTINCTION BETWEEN UNIPOLAR AND BIPOLAR DEPRESSIONS
  134. Effect of Stimulus Intensity on Prolactin and Cortisol Release Induced by Unilateral Electroconvulsive Therapy
  135. Role of serotonin3 receptors in prolactin release induced by electroconvulsive therapy: A study with ondansetron
  136. Treatment of Acute Bipolar Depression: A Review of the Literature